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Abstract
Mass spectrometry imaging (MSI) enables the visualization of molecular distributions on
complex surfaces. It has been extensively used in the field of biomedical research to investigate
healthy and diseased tissues. Most of the MSI studies are conducted in a 2D fashion where only
a single slice of the full sample volume is investigated. However, biological processes occur
within a tissue volume and would ideally be investigated as a whole to gain a more
comprehensive understanding of the spatial and molecular complexity of biological samples
such as tissues and cells. Mass spectrometry imaging has therefore been expanded to the 3D
realm whereby molecular distributions within a 3D sample can be visualized. The benefit of
investigating volumetric data has led to a quick rise in the application of single-sample 3D-MSI
investigations. Several experimental and data analysis aspects need to be considered to
perform successful 3D-MSI studies. In this review, we discuss these aspects as well as ongoing
developments that enable 3D-MSI to be routinely applied to multi-sample studies.
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Introduction
Mass spectrometry imaging (MSI) is a label-free molecular
imaging technique for which no prior knowledge about the
sample is needed. It enables the visualization of molecular
distributions on solid surfaces using mass spectrometry by
scanning the samples in a pixel-by-pixel manner where for
each pixel a mass spectrum is generated. Visualization of
molecular spatial distributions provides unique insights in
many fields such as material science and biomedical
research [1, 2]. In the latter, such surfaces are typically thin
planar sections prepared from biological tissue. MSI has
been used extensively to image the two-dimensional (2D)
distributions of endogenous or exogenous (drugs and
pharmaceuticals) compounds in such planar tissue sections
for the study of tissue-based diseases, tissue pharmacokinet-
ics, or the study of biomaterials in medical applications [3,
4]. However, the natural state of the original sample is
volumetric, hence keeping the original three-dimensional
(3D) information is important to be able to study the
structural context of the sample in all dimensions.
In material science, where MSI has been employed since
the 1960s [5], it is proven that 3D-MSI can provide essential
information. Secondary ion mass spectrometry (SIMS), for
instance, has been used extensively for 3D elemental
analysis of semiconductors, superconductors, glass, stainless
steel, solid oxide fuel cell components, aerospace alloys,
coatings, and biomaterials [6, 7]. The unique capability ofCorrespondence to: R. Heeren; e-mail: r.heeren@maastrichtuniversity.nl
obtaining molecular depth profiles has provided evidence on
how 3D-SIMS can aid in understanding complex volumetric
structures [8–13].
The benefit of acquiring more relevant information
through 3D-MSI is also of added value for biomedical
research in which the added dimension can yield
important contextual information about the biological
tissue (see ‘Benefits of 3D-MSI’). In conventional 2D
imaging, a chemical snapshot of a single tissue section is
generated. This snapshot corresponds to a specific
location in a larger sample. Tissue stereology [14] has
shown that a single section may not be representative of
the whole sample. Tissues are seldom homogeneous, and
the mix of cells across several 2D planes varies strongly,
especially in a diseased state [15]. This introduces a
potential sampling bias. In clinical diagnostics, the
discrepancy between the sampled sections and the
variation across a whole tissue can lead to inaccurate
predictions. This occurs especially in oncology where
cancer can be spatially very heterogeneous [16]. This is
corroborated by the use of radiomics in oncology, which
has shown that 3D structural features contained in
clinical in vivo scans harbor relevant clinical information
[17]. An imaging feature was found for ovarian carci-
noma that was predictive of the outcome after first
chemotherapy. In glioblastoma, a specific imaging pat-
tern was able to predict epidermal growth factor receptor
(EGFR) overexpression. Another prime example for the
necessity of volumetric investigation is the healthy brain
which has therefore been the blueprint for many 3D
omics studies [18].
Consequentially, 3D-MSI has already analyzed a variety
of solid tumor tissues, rodent brains, and other organs, and
applications are rapidly increasing [19, 20]. While these
studies provide successful use cases, they also reveal
technical aspects that require special attention and further
development beyond conventional 2D-MSI. These aspects
affect the whole study workflow and range from study
design through sample preparation to data analysis. We will
discuss them in this review, especially in the light of
extending 3D-MSI to the analysis of larger sample
(patient) cohorts to capture inter-individual effects. First,
the most commonly used 3D-MSI techniques and their
applications are briefly reviewed to illustrate the benefit of
3D-MSI in biomedical research. Then we highlight practical
considerations in performing 3D experiments and 3D data
analysis, as well as discuss remaining challenges.
3D Approaches in MSI
There are generally two different ways by which 3D-MSI
can be achieved, depending on the desorption/ionization
technique used: via surface sputtering or via the analysis of
multiple serial sections (Fig. 1).
In 3D-SIMS, surface imaging and surface sputtering,
where the impacting primary ion beam removes a
nanometer-thin layer during the sputtering cycle, are
continuously alternated until the desired depth is reached
(Fig. 1a). The depth-resolution depends on the type of ion
beam and the associated sputter rate of the region being
analyzed [21–23] but usually ranges between 10 [24] and
1 nm [25]. The use of polyatomic or cluster-based ion beams
enables small-sized biomolecules, such as lipids, to be
released intact from the surface. Additionally, the chemical,
subsurface damage done by these beams is reduced or
completely removed [2, 26]. This also allows an increased
primary ion energy to be applied. A higher primary ion
energy typically leads to higher secondary ion signal within
a single pixel and results in improved image contrast [26].
The introduction of polyatomic ion guns, like the C60
+ and
Bi3
+ ion guns with a smaller beam focus, even allows 3D
analysis of single cells as it can be focused down to
subcellular resolution and generates higher yields of intact
biomolecules [26, 27].
Soft-ionization techniques, in contrast, do not rely on
energetic sputtering but rather the soft desorption/extraction
of biomolecules. In matrix-assisted laser desorption/
ionization (MALDI) and desorption electrospray ionization
(DESI), the two most common soft-ionization techniques
used for MSI, a 3D image is obtained by serial measure-
ments of consecutive sections from a sample (Fig. 1b). The
final 3D dataset is then obtained via a reconstruction
procedure. The overall sample volume that can be analyzed
with these techniques in a given amount of time, is much
higher than with SIMS. The analysis volume depends on the
sectioning thickness (usually 10–20 μm) [28–30], the
number of sections, and the spacing between the sections.
MALDI and DESI are therefore often employed to measure
whole tissues in 3D as a result of the large volume of
analytical capabilities. However, compared with SIMS, the
depth resolution between sections is limited by the thickness
of the tissue section, which typically ranges from 4 μm
(paraffin-embedded tissue) to 12 μm (frozen tissue). Mole-
cules within a section are samples from an unknown
extraction depth determined by the MALDI matrix or DESI
solvent often assumed to be constant across a sample.
In MALDI-MSI, 3D applications have seen a recent rise
in popularity due to advances in sample preparation and
instrumentation, such as lasers with high repetition rates and
fast-moving stages, which made high-throughput analysis
possible [31–33]. As a consequence, whole tissue sections
can now be measured within minutes, which allows a full
3D dataset to be acquired within a day.
Compared with MALDI-MSI, DESI-MSI requires less
sample preparation as no external matrix is required to
extract the molecules of interest. This does not necessarily
mean a higher throughput for DESI-MSI over MALDI-MSI.
Due to a limited spray focus, DESI has a lower spatial
resolution than MALDI or SIMS. Various efforts are
ongoing to increase the lateral spatial resolution that would
allow for the acquisition of better quality images from
different histological regions within a tissue [34].
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Benefits of 3D-MSI
Early 3D-MSI experiments have demonstrated feasibility
and have paved the way for subsequent applications with
different ionization modalities [35–37]. Here, we highlight
selected applications of 3D-MSI that demonstrate its benefit
or the need to contextualize the molecular information into
an additional spatial dimension in certain situations.
3D SIMS-MSI
SIMS has been extensively used for 3D MSI studies of
single cells and tissues as reviewed by Fletcher [11, 38].
Here, we highlight two applications focused on interfaces
between drugs and surfaces. Biomaterials, like coronary
stents, are frequently studied with three-dimensional SIMS.
Coronary stents are coated with a polymer that contains an
anti-inflammatory drug that is released over time to prevent
the blocking of the stent. To visualize the distribution of the
drug sirolimus in a stent, drug/matrix-coated metal coupons
were imaged with 3D-SIMS [39]. A gold ion beam was used
for imaging in conjunction with a carbon-cluster (C60) ion
beam for sputtering, which results in low residual molecular
damage after sputtering. This is needed since sirolimus is a
mid-sized (914 g/mol) pharmaceutical compound. Sputter
rates have been determined under the same measurement
conditions on a similar polymer material to allow accurate
determination of the depth scale. It was found that large
areas of the surface and subsurface channels were composed
primarily of sirolimus, followed by a drug-depleted region,
and lastly, a relative homogeneous drug distribution in the
polymer matrix. Comparing these 3D distributions with the
elution rates showed that elution occurs relatively quickly
from the drug-enriched surface area while it proceeds more
gradually for the subsurface regions.
Supramolecular hydrogels and their capability to enhance
skin permeation of vitamin C (ascorbic acid) and its
precursor (ascorbyl glucoside) have also been investigated
with 3D-SIMS of ex vivo porcine skin [40]. Researchers
demonstrated that the hydrogel enhances skin permeation of
both compounds and preserves the conversion of the
precursor into vitamin c until it reaches the epidermal layer,
the intended target (Fig. 2a). As the depth to the epidermis is
a priori unknown and sputtering rates might change for each
layers within a sample, the authors used two methods to
calculate the z-resolution during sputtering. Optical
profilometry was applied to determine the depth of the
sputter craters. This provides an estimation of the average
depth, and a phospholipid ion marker was monitored during
sputtering to determine when the epidermis layer is reached.
3D MALDI-MSI
The application of 3D MALDI-MSI has seen a steady
increase over the past years. Some of these have been
discussed in earlier reviews, though this is only a small
fraction [2, 42], thereby missing interesting papers like the
investigation of pathogenesis in Francisella infection by
Scott et al. [43] and the feasibility assessment of 3D
Fig. 1. Schematic representation of the different approaches in 3D mass spectrometry imaging (MSI). a Secondary ion mass
spectrometry (SIMS) continuously alternates imaging and sputtering cycles. b Matrix-assisted laser desorption/ionization
(MALDI) or desorption electrospray ionization (DESI) rely on the sectioning of the sample into a stack of consecutive sections
which are then analyzed individually and their data reassembled afterward.
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MALDI-MSI with FTICR by Jones et al. [44]. One of the
most investigated organs in the field of MALDI-MSI is the
murine brain due to its molecular but morphologically well-
charted complexity [45, 46]. The high-lipid content in the
brain, which is a molecular class well compatible with
MALDI- or DESI-MSI also contributes to the frequent usage
of brain sections in MALDI-MSI.
Lipid changes upon traumatic brain injury were investi-
gated in rat brain with 3D MALDI-MSI to gain more
understanding of the biochemical alterations caused by this
neurological damage that is a major cause of death and
disability in children and young adults [47]. The researchers
obtained rat brain tissue sections every 200–250 μm
covering the entire area of the cortical-impact injury. Tissue
sections were analyzed individually using MALDI-MSI of
lipids at 70 μm spatial resolution, resulting in a voxel size of
70 × 70 × 220 μm in the final 3D dataset. The authors
observed that certain lipids are specific for either the lesion
site (e.g., PC (42:9) (m/z 856.598)) or the ventricles (e.g., PC
(m/z 797.580)) that change from rostral to caudal while
others co-localize with both regions (e.g., m/z 741.545).
Acquisition of the 3D model helped the authors gain more
insight into the changes happening throughout the brain
since the injury-related molecules are transferred via these
ventricles throughout the brain and other organs. The 3D
results provided a more global view of the impact of the
traumatic brain injury and provided insight into pathological
phenomena remote from the injury site.
With recent advances in instrumentation, especially in
laser repetition rates, synchronized stage movement, and
electronics, 3D-MSI datasets can now be generated much
faster, up to 20–50 times, allowing the acquisition of
biological or technical replicates. This was recently
demonstrated by Paine et al., who studied medulloblastoma,
the most common malignant pediatric brain tumor, in six
mouse brains by 3D MALDI-MSI of lipids. The voxel size
was 50 × 50 × 150 μm, and a total of 223 sections were
measured in this study [48]. A semi-supervised segmentation
of all tissue sections was performed first to find the
boundaries of the primary tumors to facilitate the analysis
of this large amount of data. A comparison of metastasizing
vs. nonmetastasizing primary tumors revealed ten lipids
associated with medulloblastoma metastasis. As these lipids
were observed to be very heterogeneous in their distribution
throughout the tumor, single-section 2D-MSI could have
missed the significance of these lipids due to sampling bias.
This experiment demonstrated the added value of 3D-based
analyses for tumor marker discovery and exploration. Even
if multiple sections are investigated from one sample, it is
important to prepare and analyze the sections in a reproduc-
ible manner to reduce inter-section technical variation. Paine
et al. have ensured this by batch preparation (20–25
sections) and a quality assurance approach that involved
tuning the signal intensity of each imaging run on the matrix
to ensure similar ion yields on all sections [48].
This is especially true if MSI signals are to be compared
quantitatively. For instance, Giordano et al. have employed
3D MALDI-MSI to quantify the distribution of the anti-
cancer drug paclitaxel in mesothelioma tumor-bearing mice
[41]. Tumor sections were taken every 500 μm, and
MALDI-MSI experiments were performed at 100 μm lateral
pixel size. The signal of paclitaxel was normalized to an
isotopically labeled version of paclitaxel as an internal
standard and quantified using a concentration series applied
to a separate section. It was discovered that the distribution
of the drug is influenced by the cellular heterogeneity of the
Fig. 2. Applications of 3D mass spectrometry imaging (MSI). a 3D SIMS-MSI was used to study the permeation of ascorbic
acid through ex vivo skin samples after the application of PBS or a hydrogel. The results showed a deeper permeation when a
hydrogel is used. This article was published in [40] (copyright Elsevier). b Quantitative 3D MALDI-MSI of the anti-cancer drug
paclitaxel in a malignant pleural mesothelioma tumor. Images indicate the drug is mostly located at the edge of the tumor.
Figure adapted from [41] (licensed under CC BY 4.0: http://creativecommons.org/licenses/by/4.0/). c The application of
advanced data analysis methods to a 3D DESI-MSI dataset of a human colorectal cancer sample revealed several metabolically
different tumor subgroups highlighting the heterogeneity of tumors in three dimensions. Figure adapted from [19] (published by
The Royal Society of Chemistry).
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tumor microenvironment showing its highest concentration
at the edge of the tumor and a lower abundance in the center
of the tumor with necrotic and fibrotic regions (Fig. 2b). The
more accurate description of the distribution of the com-
pounds obtained, demonstrates the added value of 3D-MSI
for the quantitation of pharmaceutical compounds.
3D DESI-MSI
Few studies have so far used DESI in a 3D fashion. An early
3D DESI-MSI study has mapped the distribution of anabolic
steroid esters through bovine muscle tissue previously
injected with these compounds [49]. The spatial resolution
in x and y was 500 μm, and the samples were spatially
separated in the z-direction by 1 cm. The 3D profile was
made at the injection site and demonstrates that the esters are
indeed inside the tissue. This excludes external contamina-
tion which is an important element in the investigation of the
illegal treatment of animals.
In a more recent study, the unique capability of MSI to
describe intra-tumoral molecular heterogeneity has been for
the first time extended to 3D by investigating a human
colorectal adenocarcinoma biopsy by 3D DESI-MSI at 100
× 100 × 100 μm voxel size [19]. The application of
advanced data analysis methods including deep learning
and parametric t-SNE mapping helped to identify tumor
subgroups and characteristic metabolites that were not
detected by classical methods such as principal component
analysis (Fig. 2c). This also exemplifies that, as the field of
3D-MSI is evolving, novel and advanced data analysis
procedures are needed to extract all biological information
from 3D-MSI data.
3D-MSI Experimental Considerations
The benefit of performing 3D mass spectrometry imaging
also comes with some additional requirements and consid-
erations in terms of sample preparation, experimental design,
and data acquisition. The evaluation of these workflow
elements is crucial to reliably correlate and compare findings
throughout a 3D-MSI volume. Below, we will discuss
several considerations that have a direct impact on the
outcome of a 3D study.
Single-Cell Preparation for SIMS
In the case of SIMS for single-cell analysis, cells need to be
prepared in such a way that the 3D shape and integrity of the
cells are maintained. One way of achieving this is by
chemical fixation of the cells to preserve the cellular
architecture of the cell [50–52]. In this process of fixation,
certain molecules, like salts, can diffuse while proteins are
cross-linked together [50, 52]. Another approach that retains
the integrity of the cells and prevents diffusion of molecules
is to prepare frozen-hydrated cells through cryo-fixation of
cells in their native hydrated state [53]. This method
achieves higher ion yields for certain chemical species but
requires the instrumentation to be equipped with a cold stage
to maintain the frozen-hydrated state of the sample through-
out the entire workflow [53, 54]. UHV systems can result in
the sublimation of water from the 3D samples which can
subsequently deteriorate during cryo-imaging experiments.
Alternatively, cells can be prepared for 3D-SIMS analyses
by freeze fracturing where cells are trapped in a frozen
sandwich, which is broken before analysis. This method
maintains both cellular and molecular integrity but can lead
to the loss of the top part of the cells and the fracture plane is
not always reproducible. This makes it difficult to charac-
terize both complementary fractured surfaces [53, 54]. All
these sample preparation methods have their advantages
(e.g., maintaining cellular integrity, preventing diffusion)
and drawbacks (e.g., diffusion of molecules, unreproducible
fracture planes), and choosing the best-suited method
depends on the research question at hand.
Serial Section Preparation
In the case of 3D-MALDI and 3D DESI-MSI, experiments
might require the collection of dozens to hundreds of (semi-
)consecutive sections from one sample. As a result, caution
is required during sectioning to exclude the loss of
individual sections and retain the appropriate order and
spacing in the 3D stack. Keeping the samples in the same
orientation in a consistent shape will, later on, simplify the
alignment of the sections into a 3D volume. Minor
misalignment of sections can be digitally corrected afterward
[55]. This registration is often based on prominent morpho-
logical features, and heavy distortion can render molecular
images unsuitable for inclusion in the 3D volume. This can
be overcome by embedding the tissue in embedding
materials like optimal cutting temperature (OCT) or gelatin
[30, 56–58]. Care has to be taken that the right embedding
material is chosen, compatible with the measurement.
Embedding with OCT is generally not recommended for
MSI as it contains a polymer which easily ionizes in
positive-ion mode and may cause ion suppression or mask
tissue-specific signals. Synthetic polymer-based embedding
media also run the risk of smearing across tissue samples
during sectioning [57]. Gelatin and CMC are biopolymer
based and generate less spectral interference, which renders
them more compatible with MSI experiments of biological
surfaces [59]. Care has to be taken that biomolecules do not
delocalize during the embedding process. Using an embed-
ding medium also allows the use of fiducial markers that can
aid in the registration process. Fiducial markers are placed in
the embedding block and may help to determine the
position, orientation, and distortion of each section. They
are also very suitable for use in the co-registration of MSI
data with images from different imaging modalities [60–62].
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Experiment Design
3D-MALDI and 3D DESI-MSI experiments consist of
the sequential measurement of serial tissue sections. If
the sections or experiments have not been properly
randomized, the entire contiguous parts of the 3D
volume might be affected by a technical bias, which
cannot be distinguished from a biological effect (Fig.
3a). It is, therefore, necessary to use randomization in
both sample preparation and data acquisition. Serial
sections should be distributed in a randomized fashion
within and between the slides already during the
sectioning process. This overcomes potential batch
effects resulting from technical variance in slide prepa-
ration (cutting, on tissue chemistry, matrix application)
and instrument-related batch effects such as a decrease or
drift of system sensitivity during long runs of
acquisition.
While randomization itself will certainly reduce a
systematic technical bias that can be confused with a
biological effect, it will not recognize technical outliers.
This becomes even more important when multiple 3D
datasets from different tissues are to be measured and
compared. The total project execution duration exceeds
classical 2D MSI projects by a factor corresponding to
the average number of sections per 3D sample. The total
sample preparation of a multi-sample 3D-MSI project can
spread over weeks and months as only a single sample
can usually be cut at a time. This increases the
possibility of observing time-related batch effects be-
tween and within 3D-MSI datasets. A way to monitor
experimental quality is the application and integration of
quality control measurements. Quality control compounds
can be applied before measurement or matrix application,
thereby independently assessing either instrument perfor-
mance or sample preparation, respectively. For instance,
protein and peptide standards can be spotted onto the
slides next to the tissue to determine matrix quality or
digestion efficiency on a slide-by-slide basis [63, 64].
Unfortunately, this is not yet routinely applied in the
field of 3D-MSI. Only recently, we have demonstrated
the usefulness of quality controls to track digestion
efficiency in a multipatient 3D-MSI study [63]. In this
study, we incorporated cytochrome c as a quality control
for digestion efficiency on a slide basis. By performing
principal component analysis (PCA) on the cytrochome c
spots and using a 95 % error ellipse, we could identify
11 slides on which the digestion was insufficient. This
translated to 22 sections out of a total 280 measured
giving a dropout rate of G 8 %. In addition to tracking
sample preparation quality, it is also a necessity to
monitor day-to-day instrumentation performance as in-
strument sensitivity can vary from one experiment to
another. Monitoring instrumentation performance with a
quality control compound measured over time can assist
in the identification of technical outliers [65].
Data Acquisition
Large volume measurements require careful planning of
the total workflow, from sample preparation to data
acquisition. Time can be a critical factor and influence
the resulting 3D molecular dataset. Sample preparation
should happen “just-in-time” before the measurements as
otherwise, degradation of the samples might occur which
might lead to false discoveries along the volume [66,
67]. Total acquisition time should be optimized to
minimize the experimental variance within one 3D-MSI
dataset while keeping throughput as high as possible.
Dataset size is another critical factor. It increases linearly
with the number of sections and samples and is quadratic
ally dependent on the spatial resolution. The resulting
total dataset size often determines the choice of optimal
spatial resolution, the mass range, and the number of
sections per sample. This also ensures during data
analysis the various software packages and algorithms
can read a full dataset in memory if so desired. We have
recently proposed a procedure to determine the minimum
number of sections needed to retain a minimum amount
of the full information extracted from a 3D MALDI-MSI
experiment [63]. This representativity analysis is based
on calculating the correlation coefficient of a subset of
samples to the full 3D dataset. In our study, we found
that every third of the measured 20 sections were needed
to reach a minimum correlation of 0.99 to the full 3D
dataset. This way, a preselected, representative sample is
defined to prospectively save sections from alike samples
and reduce the data size of the study.
3D-MSI Data Analysis Considerations
Outlier Detection
One of the challenges that MSI faces is the lack of a
generic and reliable experimental outlier detection
method to ensure a high degree of comparability for
both inter- and intra-sample comparisons. Recently, we
proposed a detection method to check for any possible
outliers in 3D-MSI datasets. The method is based on z-
directed regression analyses within a 3D volume and
identifies sections as outliers whose molecular signals
deviate statistically too much from the expected signal
intensity (Fig. 3b) [63]. This method is generic and
captures most experimental biases unless too many
sections are affected at the same time from that bias
thereby driving the regression analysis. This could be the
case if many consecutive sections are on the same slide.
These sections undergo all experimental steps at the
same time and therefore all get affected by matrix
application or a poor MS instrument performance at the
same time.
Vos D.R.N. et al.: Practical Considerations in 3D-MSI
3D Image Reconstruction
It is of interest in many studies to align and stack the
individual MSI images of a completed 3D-MSI dataset to
construct a 3D volume, which can be used for an advanced
interpretation of the spatial context of the molecular images.
Embedded fiducial markers can be used as reference points
to automatically co-register and stack the single sections
(Fig. 4a) [60]. However, the 3D volume reconstruction can
be completed without fiducial markers. This is often
performed manually by using either anatomical features in
optical images that are already aligned to the MS images
[68, 69] or well-structured MS images to spatially align the
consecutive MSI slices (Fig. 5b, c) [47, 48]. These
approaches are only suitable for tissues with well-defined
and visible structures in the optical or MS images. For the
task of aligning and reconstructing 3D visualizations,
different software applications have been used [37, 72–74],
including ImageJ (https://imagej.nih.gov/ij/) [75], R software
(https://www.r-project.org/), SCiLS Lab (Bruker Daltonik
GmbH, Bremen, Germany), or Autoaligner® combined with
Imaris (both from Bitplane, Zurich, Switzerland) [41]. With
Autoaligner® image features are used to align the sections
which are built into a volume with Imaris.[73]. In the case of
ImageJ, there are different ways to align and can be done by
first aligning stained sections using an automated rigid body
registration and then align the MSI images to this. With
SciLS, the sections are manually co-registered together
based on the shape of the sections.
Multimodal 3D Imaging
3D-MSI also opens the possibility of correlating the
volumetric molecular information with data from other
(3D) imaging modalities [76]. A common example is the
combination of 3D MALDI-MSI data with standard
histology techniques. Therefore, Lotz and coworkers
analyzed 162 consecutive sections of an oral squamous
cell carcinoma with MALDI-MSI, conventional hematox-
ylin and eosin, and immunohistochemistry. The transfer
of these two modalities (MSI and optical microscopy)
into the same coordinate system allowed all 3D data to
be viewed next to each other, which led to a better
understanding of the functional heterogeneity within the
tumor as spatial context and progression can readily be
determined from the H&E (Fig. 5a) [70]. The visual
integration of MSI data with data from in vivo imaging
techniques also harbors great potential by combining the
molecular and anatomical information from different
spatial scales. In this context, Abdelmoula et al. devel-
oped an automatic co-registration between 3D-MSI and
MRI that tackles the differences in spatial scales and
coordinate systems, the lack of direct spatial-correspon-
dences, or nonlinear tissue deformations (Fig. 5b) [71].
Spatial Statistics in 3D-MSI
3D-MSI data puts new demands on data analysis
strategies itself. It is already known in 2D-MSI that the
spatial context of the single mass spectra is a factor that
can be exploited for multivariate analyses or has to be
accounted for when performing inferential statistical
analyses. Spatial-aware segmentation, as reported by
Alexandrov and Kobarg [77], would have to be extended
to the clustering of voxels. Likewise, statistical ap-
proaches that account for the inherent spatial autocorre-
lation in MSI data would have to be extended to the
third dimension [78]. Morphometric characteristics of
Fig. 3. Experimental considerations in 3D-MSI. a When no randomization has been performed, the fluctuation of the overall
signal intensity across every single section, represented by its total ion count (TIC), can be caused by other factors such as
date of experiment, the slide, or the position of the section on the slide. b Assuming proper randomization and that close by
sections should have similar molecular signals, we have recently proposed a z-direction based regression of molecular signals.
Outliers are detected whose molecular signals are not in line with previous and successive sections. This article was published
in [63] (copyright Elsevier).
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MSI data has been shown by Picard de Muller et al. to
carry biomedical relevant information, which would also
have to be calculated on voxels instead of 2D pixels
[79].
Recently, Abdelmoula et al. have translated and
extended the nonlinear t-SNE dimensionality reduction
to the interactive visual exploration of 3D-MSI datasets
using a hierarchical version of t-SNE. They have
demonstrated that this approach can rapidly identify
regions of interest within large high-dimensionality 3D-
MSI datasets [80].
Other Data Analysis Challenges in 3D-MSI
Other, less-apparent data analysis challenges remain,
such as the calculation of average spectra across a 3D
volume when serial sections are not evenly spaced. This
requires the development of a weighted average
Fig. 4. Alignment strategies in tissue-section-based 3D-MSI. a Alignment based on embedded fiducial markers requires a
previous embedding of the sample into a medium but delivers good results. Adapted with permission from [60] (copyright
American Chemical Society). b An alignment based on optical images requires the optical images to be linked to the MSI data
before data analysis, e.g., during the experiment. c Alignment based on only the MS images requires visible and well-defined
structures in the images. The coarseness of these structures should match the spatial resolution of the MS images.
Figure adapted from [48] (licensed under CC BY 4.0: http://creativecommons.org/licenses/by/4.0/).
Fig. 5. Integration of 3D-MSI with other modalities. a A 3D MALDI-MSI dataset consisting of 162 consecutive sections of an
oral squamous cell carcinoma was combined with the corresponding 3D stack of histological images. Both volumes were
placed in the same space allowing the co-visualization of both modalities at the same depth. This article was published in [70]
(copyright Elsevier). b A 3D MALDI-MSI dataset of glioblastoma in a mouse brain was also combined with MRI. The
visualization on the left shows a molecule that highlights the tumor area and on the right, the same ion is overlaid with the MRI
image. Adapted with permission from [71] (copyright American Chemical Society).
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procedure that uses the information of the z-position of
all sections that are taken into account. A practical
challenge is the annotation of tissue regions, already a
huge bottleneck in 2D-MSI studies, and even more so in
3D-MSI studies, as multiple sections need annotation.
Semi-supervised learning approaches where partial anno-
tations by a pathologist are combined with deep learning
on the MSI data are proposed for the classification of the
remaining tissue by Inglese et al. [19]. If the sections are
consecutive and have already been aligned to form a 3D
model, one could also consider interpolating the partial
annotations throughout the volume. In that light, one
could also foresee the translation of the already existing
approaches from unbiased tissue stereology to the
molecular 3D-MSI data, where stringent sampling
methods, and geometrical and statistical principles are
used to obtain accurate and precise three-dimensional
information [14]. Ultimately, novel data analysis ap-
proaches need to be developed that (a) will enable the
researcher to extract the added information provided by
the third dimension from a 3D-MSI dataset and (b) does
not increase the manual workload for the researcher and
maintains it similar to the 2D scale.
Conclusion
Mass spectrometry imaging is an added tool for the spatially
resolved analysis of molecules in biological tissue specimens
in many fields of biomedical research. 3D-MSI studies are
gaining momentum as the benefit of the added information
from the 3rd dimension is slowly beginning to outweigh the
additional experimental and post-experimental efforts. While
the throughput is not a limitation anymore nor by sample
preparation [33] nor by instrumentation speed [31], data
handling, processing, and analysis remain bottlenecks.
Dedicated software solutions exist but still cannot alleviate
the additional data analysis workload that results from 3D
studies. This holds especially true for histological annota-
tions, spectral and image alignments, co-registration for
integration with other imaging modalities, experimental
outlier detection, and smart 3D visualizations. This has been
recognized by the field shown by the many recent
publications. Once these barriers are alleviated, 3D-MSI
will be routinely extended to multisample studies. This
results in a rapid three-dimensional, fully spatially aware
molecular biology method that will cause a paradigm shift in
patient diagnostics.
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